Home
Nanomerics
Deliver more
  • Home
  • Company
    • Company
    • Who we are
    • Contact Us
  • Products
    • Products
    • Pipeline
    • NM133
    • NM127
    • NM147
  • Technology
    • Technology
    • Molecular Envelope Technology
  • Science
    • Science
    • Publications
  • News
  • Home

Biblio

Found 5 results
Filters: Author is Lalatsa, Aikaterini  [Clear All Filters]
2017
Godfrey L, Iannitelli A, Garrett NLaura, Moger J, Imbert I, King T, Porreca F, Soundararajan R, Lalatsa A, Schätzlein AG et al..  2017.  Nanoparticulate peptide delivery exclusively to the brain produces tolerance free, analgesia.. Journal of Controlled Release. E-pub ahead of print
2015
Serrano DR, Lalatsa A, M Dea-Ayuela A, Bilbao-Ramos PE, Garrett NL, Moger J, Guarro J, Capilla J, M Ballesteros P, Schätzlein AG et al..  2015.  Oral particle uptake and organ targeting drives the activity of amphotericin B nanoparticles.. Molecular pharmaceutics. 12(2):420-431.
2014
Lalatsa A, Schätzlein AG, Uchegbu IF.  2014.  Strategies To Deliver Peptide Drugs to the Brain. Molecular pharmaceutics. 11(4):1081-1093.
2012
Garrett NLaura, Lalatsa A, Uchegbu I, Schatzlein A, Moger J.  2012.  Exploring uptake mechanisms of oral nanomedicines using multimodal nonlinear optical microscopy. Journal of Biophotonics. 5(5-6):458-468.
Lalatsa A, Lee V, Malkinson JP, Zloh M, Schätzlein AG, Uchegbu IF.  2012.  A Prodrug Nanoparticle Approach for the Oral Delivery of a Hydrophilic Peptide, Leucine 5-enkephalin, to the Brain. Molecular pharmaceutics. 9(6):1665-1680.
Stay up to date

Contact Us

Registered Office

  • Address:
    6th Floor, 2 London Wall PlACE
    London
    EC2Y 5AU
    United Kingdom

  • Phone: +44 (0) 20 3397 2183

  • Fax:     +44 (0) 20 3397 2184

  • Email: email

Follow Us

Nanomerics © Copyright 2017 by Nanomerics. 

  • Sitemap
  • Contact